TNF and Alzheimer disease: With regards to AD, cannabinoids, including the CB2 selective agonist JWH133, were demonstrated to block Aβ peptide-induced activation of microglia in vitro, including a reduction in the release of the pro-inflammatory cytokine TNF-α, which is associated with the cytotoxic microglial phenotype, and a reduction in mitochondrial activity [290].